## HRL: Hormel Foods Corporation - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_20 0.2% below STRENGTH zone (4.0-10.0%); PEG 3.37 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-3.3% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($22.72)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 5, Bearish: 0)

**1. Hormel Foods creates a chief marketing officer role**
- Source: Digital Commerce 360 | 20251218T190828 | Bullish | Relevance: 100%
- Hormel Foods Corp. has appointed Jason Levine as its first Chief Marketing Officer, a newly created enterprise-wide position. Levine brings over two decades of consumer-packaged goods marketing experience from companies like Mondelēz International and PIM Brands. His role will focus on strengthening marketing execution, brand strategy, digital marketing, and leveraging data and technology for long-term growth across Hormel's portfolio.

**2. Hormel Foods Sells Majority Stake in Justin’s to Investment Firm**
- Source: FoodEngineeringMag.com | 20251218T150808 | Somewhat-Bullish | Relevance: 100%
- Hormel Foods has formed a strategic partnership with Forward Consumer Partners, a private investment firm, selling a 51% majority stake in the Justin's brand while retaining 49%. This new structure makes Justin's a standalone company, welcoming back founder Justin Gold as a strategic advisor and former CEO Peter Burns as the new CEO. The move aims to provide the focus and resources necessary for Justin's to grow, with a seasoned leadership team and board bringing extensive experience in building consumer brands.

**3. Why Hormel is struggling to profit off America’s protein obsession**
- Source: Star Tribune | 20251217T120100 | Somewhat-Bearish | Relevance: 100%
- Hormel, a company synonymous with pork and other protein products, is struggling to capitalize on America's protein obsession despite expanding its offerings. High input costs for products like pork bellies and unforeseen events like a peanut butter facility fire and avian flu outbreaks have eroded profits, causing Hormel's stock to drop. Despite these challenges, Hormel's sales have edged up, and the company is focusing on leveraging its diverse protein portfolio and traditional food sources, while analysts predict a stronger performance in 2026 due to anticipated lower costs.

**4. Hormel Names Enterprise-wide Chief Marketing Officer**
- Source: Meatingplace | 20251219T182223 | Somewhat-Bullish | Relevance: 100%
- Hormel Foods Corp. has appointed Jason Levine as its new enterprise-wide chief marketing officer to strengthen its consumer-centric strategy. Levine brings over two decades of experience in the consumer packaged goods industry, including roles at PIM Brands and Mondelez International. He will focus on advancing marketing capabilities, brand strategy, digital initiatives, and aligning innovation with business analytics.

**5. Hormel Creates New Enterprise-Wide Chief Marketing Officer Position**
- Source: Progressive Grocer | 20251219T140830 | Bullish | Relevance: 100%
- Hormel Foods Corp. has appointed Jason Levine to the newly created role of enterprise-wide chief marketing officer (CMO) to bolster its marketing capabilities and drive growth. Levine brings over two decades of experience in the consumer packaged goods industry, having previously served as CMO for Mondelēz International for North America and PIM Brands. His new role will focus on advancing brand strategy, digital capabilities, and integrating business analytics to support data-driven marketing and innovation across Hormel's global brands.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 3, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-09 | Barclays | $30 | $31 | -3% |
| 2025-12-05 | Piper Sandler | $26 | $25 | +4% |
| 2025-12-05 | JP Morgan | $28 | $27 | +4% |
| 2025-12-05 | B of A Securiti | $26 | $25 | +4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-09 | Barclays | main | Overweight |
| 2025-12-05 | Piper Sandler | main | Neutral |
| 2025-12-05 | JP Morgan | main | Overweight |
| 2025-12-05 | B of A Securiti | main | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 12 ($0.26M) |
| Sells | 8 ($0.46M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 24.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 10 / 0 |

**Top Holders:**
- Vanguard Group Inc: 6.8% (+2.0%)
- State Street Corpora: 5.1% (+1.0%)
- Blackrock Inc.: 4.6% (+2.2%)
- Invesco Ltd.: 2.1% (+66.5%)
- Geode Capital Manage: 1.5% (+1.7%)

### Key Risks

1. Valuation risk: PEG 3.4x with declining EPS estimates leaves no margin for error.
2. Long-term trend broken: trading 13.5% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Analyst target momentum: 3 raises (avg +4%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 3.37 signals overvaluation risk, limited margin of safety. Forward P/E 15.2x stretched relative to 6% growth. Balance sheet: strong liquidity (2.5x). Institutional flow bullish (10 buying vs 0 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $13.0B |
| Beta | 0.33 |
| 52W Range | $21.03 - $32.07 |
| Short Interest | 5.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.37 |
| Forward P/E | 15.2 |
| Current P/E | 16.2 |
| YoY Growth | 6.3% |
| EPS Direction | FALLING |

### Technicals

MRS_20 deteriorating from 3.5% to 0.2% (-3.3% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.8pp (needs >4.0% for momentum thesis). MRS_5 (-1.9%) diverging from MRS_20 - short-term weakness emerging. Below SMA200 (0.86x), long-term trend not supportive. RSI neutral at 53. OFD pattern: -MTN (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 0.20% (CS: 54) | Neutral |
| RSI_14 | 53.3 | Neutral |
| MACD Histogram | 0.02 | Bullish |
| vs SMA20 | 1.005x | Above |
| vs SMA50 | 1.025x | Above |
| vs SMA200 | 0.865x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $23.68
- **Stop Loss:** $22.72 (4.1% risk)
- **Target:** $24.64 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 1249
- **Position Value:** $29,576.32
- **Portfolio %:** 29.58%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with improving risk appetite as VIX falls to 6th percentile and tech rally resumes on AI infrastructure demand. Fed pause expectations from cooling CPI data support equities, though elevated put/call ratio suggests cautious positioning. Focus on quality names in AI-exposed sectors.*

### Earnings

**Next:** 2026-02-26 (Est: $0.32)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $0.30 | $0.32 | +6.0% |
| 2025Q3 | $0.41 | $0.35 | -14.5% |
| 2025Q2 | $0.34 | $0.35 | +3.3% |
| 2025Q1 | $0.37 | $0.35 | -6.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*